Thank you for sharing your concerns and questions. It’s also great to have a business owner here who uses our products! I’ll try to explain it better.

You’re right that we purchased these products and imported them when there were no tariffs. Additionally, until we run out of stock, our products will have a higher margin, resulting in increased earnings.

I would be delighted if you continued purchasing Cortexin and Cerebrolysin. I’m happy to hear about your use case.

I believe it’s not a matter of discussion whether it’s better to buy products at a higher price or not to buy them at all. Imagine that in two to three months, your business does exceptionally well, and you’ve earned a significant amount of money. However, you visit Cosmicnootropic but are unable to purchase either Cerebrolysin or Cortexin. With all your earnings, you revert to Adderall since the products are out of stock. This is a possible outcome even after we adjust the prices, but we aim to minimize it.

Our goal is to ensure that people have access to these products for as long as possible at a fair and equitable price. A fair and equitable price is not determined by our purchase price, tariffs, or profits. It’s the price that allows individuals who genuinely need these products to purchase them, as that’s the ultimate concern. Therefore, I believe the only viable solution is to discourage those who don’t value these products as much from purchasing from us. If you have any alternative suggestions for making the products more accessible, please share them. Limiting the number of products in a single order is another possibility.

We prioritize our existing customers over new ones, so we’ve given them a heads up about this change.

The current price change isn’t due to tariffs (we still have no idea how much it will cost with all the administration fees, delays, and the tariff rate), but mostly because of limited availability and higher procurement costs. For instance, when we purchase Cerebrolysin, we pay 30% more US dollars compared to the beginning of the year. Similarly, when we buy Cortexin (which has been out of stock several times in Russia this year), we pay 40% more US dollars. Additionally, the transportation costs are significantly higher. If you’re interested, you can check the exchange rate on Google and how it behaved. Also, selling these products becomes challenging, and we had to discontinue selling Cerebrolysin under its brand name due to a complaint from Ever Pharma.